1 in 4 Medicare beneficiaries with obesity could get Wegovy despite coverage ban
An estimated 3.6 million Medicare beneficiaries could potentially access Wegovy now that the Food and Drug Administration (FDA) approved the drug for reducing the risk of incidents related to cardiovascular disease. A KFF analysis found that among the 13.7 million people on Medicare diagnosed with obesity, 3.6 million, or roughly 1 in 4, of these...